Baroda, India

Milan Natvarbhai Thakkar

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Milan Natvarbhai Thakkar

Introduction

Milan Natvarbhai Thakkar is a notable inventor based in Baroda, India. He has made significant contributions to the field of pharmaceuticals, holding three patents that showcase his innovative spirit and dedication to improving medical treatments.

Latest Patents

Thakkar's latest patents include a parenteral dosage form of diltiazem. This invention relates to a ready-to-infuse, stable aqueous solution comprising diltiazem or its pharmaceutically acceptable salt, a pH adjusting agent to provide a pH in the range of 3 to 5, and ethanol. Another significant patent is for a parenteral dosage form of norepinephrine. This invention involves a ready-to-administer parenteral dosage form of norepinephrine, which comprises an aqueous solution of norepinephrine with an anti-oxidant that is not a sulfite anti-oxidant, ensuring stability at room temperature for a prolonged period.

Career Highlights

Throughout his career, Thakkar has worked with prominent companies, including Sun Pharmaceutical Industries Limited. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical medical needs.

Collaborations

Thakkar has collaborated with talented individuals such as Samarth Kumar and Kandarp Maheshkumar Dave. These partnerships have contributed to the success of his inventions and the advancement of pharmaceutical research.

Conclusion

Milan Natvarbhai Thakkar's contributions to the pharmaceutical industry through his patents reflect his commitment to innovation and improving healthcare solutions. His work continues to inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…